We're thrilled JMI Labs is part of Сòòò½APP, and we continue to provide critical antimicrobial surveillance studies through the SENTRY program. Your study will benefit from our more than two decades of extensive experience performing surveillance studies for new drug development and post-marketing monitoring of approved drugs. Every year, we receive around 40,000 clinical isolates of bacteria and fungi through a network of more than 150 medical centers from more than 35 countries worldwide. .
Antimicrobial surveillance services
We use a consortium-based participation model, which allows for inclusion at a complete or partial level geographic, pathogen or indication specific.
- Isolates are consecutively collected by site of infections
- Susceptibility testing by reference broth microdilution methods
- CLSI and EUCAST breakpoints
- Real-time data monitoring for trend analysis of antimicrobial resistance patterns
- Resistance mechanism detection by whole genome sequencing
Know more about SENTRY
Expand the box below for answers to the most frequently asked questions about the SENTRY Antimicrobial Surveillance Program. Scroll down for links to access SENTRY. Interested in conducting an antimicrobial surveillance study? Fill out a short form to request information.
Learn more
Drug Discovery and Development
Discover active drug candidates faster and accelerate time to market with Сòòò½APP's integrated CDMO services platform that supports the entire development lifecycle.
 Bacterial and Fungal Phase I-IV Clinical Trial Support
Streamline research and accelerate development of new treatments. Services include study design, regulatory support, and data management.Â
Microbiome Testing and Analysis
From DNA sequencing to microbiome profiling, we offer a full range of microbiome analysis services tailored to your specific needs.
Expert Medical Writing Services
Effectively communicate research findings and clinical data. Our experienced medical writers offer manuscript writing, regulatory document prep, and more.